SNBCare

Esketamine nasal spray for depression is a prescription treatment option for adults with treatment-resistant depression (TRD) or major depressive disorder in specific clinical situations, as determined by a licensed healthcare provider. Although many adults improve with traditional antidepressants, some continue to experience persistent symptoms that affect daily functioning, relationships, and overall well-being.

Fortunately, esketamine nasal spray for depression offers treatment option that may complement a comprehensive mental health care plan. At SNBCare, licensed mental health providers in Massachusetts and Rhode Island perform comprehensive psychiatric evaluations and, when clinically appropriate, provide REMS-compliant Spravato® (esketamine) treatment alongside therapy, medication management, and ongoing behavioral health support.

Additionally, SNBCare follows HIPAA-compliant privacy standards while delivering individualized, patient-centered mental health care.


What Is Esketamine Nasal Spray for Depression?

Esketamine nasal spray for depression is a prescription medication administered under medical supervision in a certified healthcare setting. Unlike traditional oral antidepressants that primarily affect serotonin, esketamine works differently by targeting glutamate pathways involved in mood regulation and brain connectivity.

According to the National Institute of Mental Health (NIMH), depression affects millions of adults each year, and some individuals require additional treatment options when symptoms persist despite standard therapies.

Furthermore, licensed psychiatric providers determine whether esketamine treatment is appropriate after completing a comprehensive psychiatric evaluation.


How Esketamine Nasal Spray Works

Esketamine nasal spray works by influencing glutamate receptors that play an important role in communication between brain cells.

During treatment:

  • Patients self-administer the nasal spray under direct medical supervision.
  • Providers monitor patients throughout the treatment session.
  • Treatment takes place in a REMS-certified clinical setting.
  • Patients remain under observation for at least two hours after administration.

Additionally, providers evaluate each patient’s response during follow-up visits and adjust the overall treatment plan when appropriate.

Because every individual’s symptoms differ, providers personalize treatment recommendations based on clinical needs.


Who May Benefit From Esketamine Nasal Spray for Depression?

In general, licensed providers may consider esketamine nasal spray for adults who:

  • Have treatment-resistant depression.
  • Continue experiencing depressive symptoms despite previous antidepressant treatment.
  • Participate in ongoing psychiatric care.
  • Can attend supervised in-office treatment sessions.
  • Meet clinical eligibility requirements after evaluation.

Moreover, providers determine eligibility through individualized assessments rather than diagnosis alone.


Symptoms Associated With Treatment-Resistant Depression

Although depression affects each person differently, adults with treatment-resistant depression may experience:

  • Persistent sadness
  • Loss of interest in enjoyable activities
  • Fatigue or reduced energy
  • Difficulty concentrating
  • Changes in sleep patterns
  • Feelings of hopelessness
  • Reduced motivation

Because these symptoms may interfere with work, family life, and personal relationships, professional evaluation is essential.


The Evaluation Process at SNBCare

First, patients complete a comprehensive psychiatric evaluation with a licensed mental health provider.

During the evaluation, providers review:

  • Mental health history
  • Previous antidepressant treatments
  • Current symptoms
  • Medical history
  • Daily functioning
  • Treatment goals

Additionally, providers determine whether esketamine nasal spray fits within an individualized treatment plan.

Because patient safety remains a priority, providers carefully evaluate each individual’s medical and psychiatric history before recommending treatment.


What Happens During Treatment?

Next, eligible patients receive treatment in a supervised clinical environment.

During each appointment:

  • Patients self-administer the nasal spray under provider supervision.
  • Clinical staff monitor patients throughout the session.
  • Providers observe patients for at least two hours after dosing.
  • Patients arrange transportation home because they should not drive after treatment.

Furthermore, providers schedule regular follow-up appointments to evaluate progress and adjust care when necessary.


Potential Benefits of Esketamine Nasal Spray for Depression

Although treatment outcomes vary, some adults may experience:

  • Improvement in depressive symptoms
  • Better engagement in therapy
  • Increased emotional stability
  • Enhanced daily functioning
  • Greater participation in mental health care

Therefore, providers often combine esketamine treatment with psychotherapy, medication management, and behavioral health support.


Safety and Possible Side Effects

Because esketamine is a prescription medication with specific safety requirements, treatment occurs only in REMS-certified healthcare settings.

For example, some patients may experience:

  • Dizziness
  • Nausea
  • Temporary dissociation
  • Sleepiness
  • Increased blood pressure shortly after treatment
  • Headache

However, licensed clinicians monitor patients throughout each visit and provide appropriate medical supervision.


Therapy and Behavioral Health Support

Meanwhile, comprehensive depression care extends beyond medication alone.

Integrated treatment may include:

  • Individual therapy
  • Medication management
  • Psychiatric follow-up
  • Behavioral health counseling
  • Lifestyle support
  • Telehealth appointments when appropriate

As a result, patients receive coordinated care that addresses multiple aspects of emotional well-being.


Telehealth Support for Ongoing Care

Although esketamine nasal spray requires in-office administration, telehealth services may support continued treatment.

Virtual appointments may include:

  • Therapy sessions
  • Medication follow-up visits
  • Progress monitoring
  • Mental health counseling

Consequently, telehealth services help many adults maintain continuity of care between office visits.


Why Choose SNBCare for Esketamine Nasal Spray for Depression?

Moreover, SNBCare provides comprehensive behavioral health services for adults throughout Massachusetts and Rhode Island.

Services include:

  • Comprehensive psychiatric evaluations
  • REMS-compliant Spravato® treatment
  • Medication management
  • Individual therapy
  • Telehealth mental health services
  • Ongoing psychiatric monitoring

Additionally, licensed clinicians focus on ethical, and patient-centered care while maintaining HIPAA-compliant privacy standards.


Frequently Asked Questions

What is esketamine nasal spray for depression?

Esketamine nasal spray is a prescription treatment administered under medical supervision for eligible adults with treatment-resistant depression or other approved clinical indications.


Can I use esketamine nasal spray at home?

No. Providers administer and monitor treatment only in REMS-certified healthcare settings.


How long does each treatment session last?

Patients typically remain in the clinic for at least two hours after receiving treatment so providers can monitor their response.


Can therapy be combined with esketamine treatment?

Yes. Providers often recommend combining esketamine treatment with therapy, medication management, and ongoing psychiatric care.


Is treatment confidential?

Yes. SNBCare follows HIPAA privacy standards designed to protect patient health information.


Finding Esketamine Nasal Spray for Depression in Massachusetts and Rhode Island

Adults searching online for “esketamine nasal spray for depression,” “Spravato treatment near me,” or “treatment-resistant depression treatment” can access behavioral health services through SNBCare.

First, patients complete a comprehensive psychiatric evaluation. Next, providers determine whether esketamine treatment is clinically appropriate and develop an individualized care plan.

To learn more about esketamine nasal spray for depression, visit SNBCare or call 781-666-2711.


Disclaimer

This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. SNBCare provides outpatient behavioral health services for adults in Massachusetts and Rhode Island. Spravato® (esketamine) is available only by prescription and must be administered in a REMS-certified healthcare setting under the supervision of licensed healthcare professionals. Treatment recommendations are based on individualized clinical evaluations.